A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
We describe herein an assay by coupling DNA adenine methyltransferase identification (DamID) to high throughput sequencing (DamID-seq). This improved method provides a higher resolution and a wider dynamic range, and allows analyzing DamID-seq data in conjunction with other high throughput sequencing data such as ChIP-seq, RNA-seq, etc.
The DNA adenine methyltransferase identification (DamID) assay is a powerful method to detect protein-DNA interactions both locally and genome-wide. It is an alternative approach to chromatin immunoprecipitation (ChIP). An expressed fusion protein consisting of the protein of interest and the E. coli DNA adenine methyltransferase can methylate the adenine base in GATC motifs near the sites of protein-DNA interactions. Adenine-methylated DNA fragments can then be specifically amplified and detected. The original DamID assay detects the genomic locations of methylated DNA fragments by hybridization to DNA microarrays, which is limited by the availability of microarrays and the density of predetermined probes. In this paper, we report the detailed protocol of integrating high throughput DNA sequencing into DamID (DamID-seq). The large number of short reads generated from DamID-seq enables detecting and localizing protein-DNA interactions genome-wide with high precision and sensitivity. We have used the DamID-seq assay to study genome-nuclear lamina (NL) interactions in mammalian cells, and have noticed that DamID-seq provides a high resolution and a wide dynamic range in detecting genome-NL interactions. The DamID-seq approach enables probing NL associations within gene structures and allows comparing genome-NL interaction maps with other functional genomic data, such as ChIP-seq and RNA-seq.
DNA adenine methyltransferase identification (DamID) 1,2 is a method to detect protein-DNA interactions in vivo and is an alternative approach to chromatin immunoprecipitation (ChIP) 3. It uses a relatively low amount of cells and does not require chemical cross-linking of protein with DNA or a highly specific antibody. The latter is particularly helpful when the target protein is loosely or indirectly associated with DNA. DamID has been successfully used to map the binding sites of a variety of proteins including nuclear envelope proteins 4-10, chromatin associated proteins 11-13, chromatin modifying enzymes 14, transcription factors and co-factors15-18 and RNAi machineries 19. The method is applicable in multiple organisms including S. cerevisiae 13, S. pombe 7, C. elegans 9,17, D. melanogaster 5,11,18,20, A. thaliana 21,22 as well as mouse and human cell lines 6,8,10,23,24.
The development of the DamID assay was based on the specific detection of adenine-methylated DNA fragments in eukaryotic cells that lack endogenous adenine methylation 2. An expressed fusion protein, consisting of the DNA-binding protein of interest and E. coli DNA adenine methyltransferase (Dam), can methylate the adenine base in GATC sequences that are in spatial proximity (most significantly within 1 kb and up to roughly 5 kb) to the binding sites of the protein in the genome 2. The modified DNA fragments can be specifically amplified and hybridized to microarrays to detect the genomic binding sites of the protein of interest 1,25,26. This original DamID method was limited by the availability of microarrays and the density of predetermined probes. We have therefore integrated high throughput sequencing into DamID 10 and designated the method as DamID-seq. The large number of short reads generated from DamID-seq enables precise localization of protein-DNA interactions genome-wide. We found that DamID-seq provided a higher resolution and a wider dynamic range than DamID by microarray for studying genome-nuclear lamina (NL) associations 10. This improved method allows probing NL associations within gene structures 10 and facilitates comparisons with other high throughput sequencing data, such as ChIP-seq and RNA-seq.
The DamID-seq protocol described here was initially developed for mapping genome-NL associations 10. We generated a fusion protein by tethering mouse or human Lamin B1 to E. coli DNA adenine methyltransferase and tested the protocol in 3T3 mouse embryonic fibroblasts, C2C12 mouse myoblasts 10 and IMR90 human fetal lung fibroblasts (data not published). In this protocol, we start with constructing vectors and expressing Dam-tethered fusion proteins by lentiviral infection in mammalian cells 24. Next, we describe the detailed protocols of amplifying adenine-methylated DNA fragments and preparing sequencing libraries that should be applicable in other organisms.
1. Generation and Expression of Fusion Proteins and Free Dam Proteins
2. Amplify Adenine-methylated DNA Fragments
3. Library Preparation for High-throughput Sequencing
The Dam-V5-LmnB1 fusion protein was verified to be co-localized with the endogenous Lamin B protein by immunofluorescence staining (Figure 1).
The successful PCR amplification of adenine-methylated DNA fragments is a key step for DamID-seq. The experimental samples should amplify a smear of 0.2 - 2 kb while the negative controls (without DpnI, without ligase or without PCR template) should result in no-or clearl...
Whether Dam-tagged proteins retain the functions of endogenous proteins should be examined before a DamID-seq experiment. The subcellular localization of Dam-tagged nuclear envelope proteins should always be determined and compared with that of the endogenous proteins. For studying transcription factors, it is suggested to examine whether the Dam-fusion protein can rescue the functions of the endogenous protein in regulating gene expression. This functional test can be performed in organisms in which knockout mutants of ...
The authors have nothing to disclose.
We thank Dr. Bas van Steensel for providing the DamID mammalian expression vectors. We thank Yale Center for Genome Analysis and the Genomics Core in Yale Stem Cell Center for advice on preparing NGS libraries and implementing high throughput DNA sequencing. This work was supported by the startup funding from Yale School of Medicine, a Scientist Development Grant from American Heart Association (12SDG11630031) and a Seed Grant from Connecticut Innovations, Inc. (13-SCA-YALE-15).
Name | Company | Catalog Number | Comments |
ViraPower Lentiviral Expression Systems | Life Technologies | K4950-00, K4960-00, K4970-00, K4975-00, K4980-00, K4985-00, K4990-00, K367-20, K370-20, and K371-20 | |
Gateway BP Clonase II Enzyme Mix | Life Technologies | 11789-020 | |
Gateway LR Clonase II Enzyme Mix | Life Technologies | 11791-020 | |
DNeasy Blood & Tissue Kit (250) | QIAGEN | 69506 or 69504 | |
Gateway pDONR 201 | Life Technologies | 11798-014 | |
293T cells | American Type Culture Collection | CRL-11268 | |
Trypsin-EDTA (0.05%), phenol red | Life Technologies | 25300-054 | |
DMEM, high glucose, pyruvate | Life Technologies | 11995-065 | |
Fetal Bovine Serum | Sigma | F4135 | |
Tris | brand not critical | ||
EDTA | brand not critical | ||
200 Proof EtOH | brand not critical | ||
Isopropanol | brand not critical | ||
Sodium Acetate | brand not critical | ||
DpnI | New England Biolabs | R0176 | supplied with buffer |
DamID adaptors "AdRt" and "AdRb" | Integrated DNA Technologies | sequences available in ref. 24; no phosphorylation of the 5' or 3' end to prevent self-ligation. | |
T4 DNA Ligase | Roche Life Science | 10481220001 | supplied with buffer |
DpnII | New England Biolabs | R0543 | supplied with buffer |
DamID PCR primer "AdR_PCR" | Integrated DNA Technologies | sequences available in ref. 24 | |
Deoxynucleotide (dNTP) Solution Set | New England Biolabs | N0446 | 100 mM each of dATP, dCTP, dGTP and dTTP |
Advantage 2 Polymerase Mix | Clontech | 639201 | supplied with buffer |
1Kb Plus DNA Ladder | Life Technologies | 10787018 | 1.0 µg/µl |
QIAquick PCR Purification Kit | QIAGEN | 28104 or 28106 | |
MinElute PCR Purification Kit | QIAGEN | 28004 or 28006 | for an elution volume of less than 30 µl |
SPRI beads / Agencourt AMPure XP | Beckman Coulter | A63880 | apply extra mixing and more elution time if less than 40 µl elution buffer is used |
Buffer EB | QIAGEN | 19086 | |
NEBNext dsDNA Fragmentase | New England Biolabs | M0348 | supplied with buffer |
T4 DNA Ligase Reaction Buffer | New England Biolabs | B0202 | |
T4 DNA Polymerase | New England Biolabs | M0203 | |
DNA Polymerase I, Large (Klenow) Fragment | New England Biolabs | M0210 | |
T4 Polynuleotide Kinase | New England Biolabs | M0201 | |
Klenow Fragment (3’ → 5’ exo-) | New England Biolabs | M0212 | supplied with buffer |
sequencing adaptors | Integrated DNA Technologies | sequences available in ref. 28 | |
Quick Ligation Kit | New England Biolabs | M2200 | used in 3.4.3; supplied with Quick Ligation Reaction Buffer and Quick T4 DNA Ligase |
sequencing primer 1 and 2 | Integrated DNA Technologies | sequences available in ref. 28 | |
KAPA HiFi PCR Kit | Kapa Biosystems | KK2101 or KK2102 | supplied with KAPA HiFi DNA Polymerase, 5x KAPA HiFi Fidelity Buffer and 10 mM dNTP mix |
agarose | Sigma Aldrich | A4679 | |
ethidium bromide | Sigma Aldrich | E1510-10ML | 10 mg/ml |
QIAquick Gel Extraction Kit | QIAGEN | 28704 or 28706 | |
iTaq Universal SYBR Green Supermix | Bio-Rad Laboratories | 1725121 or 1725122 | |
Spectrophotometer | brand not critical | ||
0.45 μm PVDF Filter | brand not critical | ||
25 ml Seringe | brand not critical | ||
10 cm Tissue Culture Plates | brand not critical | ||
6-well Tissue Culture Plates | brand not critical | ||
S1000 Thermal Cycler | Bio-Rad Laboratories | ||
C1000 Touch Thermal Cycler | Bio-Rad Laboratories | for qPCR | |
Vortex Mixer | brand not critical | ||
Dry Block Heater or Thermomixer | brand not critical | ||
Microcentrifuge | brand not critical | ||
Gel electrophoresis system with power supply | brand not critical | ||
Magnet stand | for purification of DNA with SPRI beads; should hold 1.5-2 ml tubes; brand not critical | ||
UV transilluminator | brand not critical | ||
E-gel electrophoresis system | Life Technologies | G6400, G6500, G6512ST |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved